Luiz Felipe M Prota,
Roberta M Lassance,
Tatiana Maron-Gutierrez,
Raquel C Castiglione,
Cristiane Souza Baez Garcia,
Maria Cristina Ebole Santana,
Jackson Souza-Menezes,
Soraia C Abreu,
Vivian Samoto,
Marcelo Felipe Santiago, Vera Luiza Capelozzi,
Christina Maeda Takiya,
Patricia R M Rocco,
Marcelo M Morales
[show abstract]
[hide abstract]
ABSTRACT: The aim of this study was to test the hypothesis that bone marrow mononuclear cell (BMDMC) therapy led an improvement in lung mechanics and histology in endotoxin-induced lung injury. Twenty-four C57BL/6 mice were randomly divided into four groups (n = 6 each). In the acute lung injury (ALI) group, Escherichia coli lipopolysaccharide (LPS) was instilled intratracheally (40 μg, IT), and control (C) mice received saline (0.05 ml, IT). One hour after the administration of saline or LPS, BMDMC (2 × 10(7) cells) was intravenously injected. At day 28, animals were anesthetized and lung mechanics [static elastance (E(st)), resistive (ΔP(1)), and viscoelastic (ΔP(2)) pressures] and histology (light and electron microscopy) were analyzed. Immunogold electron microscopy was used to evaluate if multinucleate cells were type II epithelial cells. BMDMC therapy prevented endotoxin-induced lung inflammation, alveolar collapse, and interstitial edema. In addition, BMDMC administration led to epithelial and endothelial repair with multinucleated type II pneumocytes. These histological changes yielded a reduction in lung E(st), ΔP(1), and ΔP(2) compared to ALI. In the present experimental ALI model, the administration of BMDMC yielded a reduction in the inflammatory process and a repair of epithelium and endothelium, reducing the amount of alveolar collapse, thus leading to an improvement in lung mechanics.
Cell Transplantation 05/2010; 19(8):965-71. · 5.13 Impact Factor
